I don’t remember if anybody remembers our year-end call, but I was asked about the strong flu season at the time because everybody was talking about the accelerated deaths during the flu season. And memories are very short, Alex. I was asked about that on our year-end call, are we seeing that into the early part of the year, which we were into January. And in that call, I said, look, this reminds me of 1994 when I got my first group, and they had a huge flu season in Chattanooga, North Georgia. And at the end of January, I annualized it and said, oh my god. I’m going to be rich. And by the end of the year, I was poor, and that’s when I started learning about seasonality and unpredictability of this. Yes, by year-end, I would assume that we’ll be back about flat or up. And when we do a deep dive through our portfolio, Alex, we don’t pay attention to CDC or anything else. We look at the market – market-by-market and competitor by competitor over long periods of time. We track each business against their competitor each month for 10 years. Our people know where they’re losing market share, whether or not where the death rate is up or down, for no reason. And that’s what we care about. And so this is, like I said, a temporary aberration. Am I not worried about it? No. I’ve seen this so many times in 27.5 years, and I lost count. And what I’m excited about is what we’re doing in operations and what the future looks like, not just by year-end, but over the next three or four or five years. If we have not issued these bonds, let me put it another way, and found out several things over the last several years. Number one, our balance sheet was screwed up because of the converts. Number two, a lot of equity investors felt like we were overleveraged. We bought in our shares a few times knowing we’d have to repurchase the converts. If – and we’re about 4.5 times. I don’t think Ben touched on the leverage right now that we’re about 4.5 times. Is that right, Ben?